185613-69-8 ((8S,9R,10R,11S,13S,14R,16S,17R)-8-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one,(8S,9R,10R,11S,13S,14R,16S,17R)-8-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one)

CAS号:
185613-69-8
中文名称:
(8S,9R,10R,11S,13S,14R,16S,17R)-8-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
英文名称:
(8S,9R,10R,11S,13S,14R,16S,17R)-8-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
分子式:
C28H37FO7
分子量:
504.587592840195

(8S,9R,10R,11S,13S,14R,16S,17R)-8-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one(185613-69-8)名称与标识符

名称

中文别名:
(8S,9R,10R,11S,13S,14R,16S,17R)-8-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one;倍他米松EP杂质I;9-去氟-8-氟倍他米松;倍他米松杂质I(EP);倍他米松H;
英文别名:
(8S,9R,10R,11S,13S,14R,16S,17R)-8-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one;Betamethasone EP Impurity I;Betamethasone Impurity 9(Betamethasone EP Impurity I);Pregna-1,4-diene-3,20-dione, 8-fluoro-11,17,21-trihydroxy-16-methyl-, (8α,9β,11β,16β)- (9CI);9-Desfluoro-8-fluoro Betamethasone;9-Desfluoro-8-fluoro Betamethasone DISCONTINUED;185613-69-8;Pregna-1,4-diene-3,20-dioneE, 8-fluoro-11,17,21-trihydroxy-16-methyl-, (8alpha,9beta,11beta,16beta)-;PREGNA-1,4-DIENE-3,20-DIONE, 8-FLUORO-11,17,21-TRIHYDROXY-16-METHYL-, (8.ALPHA.,9.BETA.,11.BETA.,16.BETA.)-;71SLU9RKCB;(8alpha,9beta,11beta,16beta)-8-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione;DTXCID5094286;BETAMETHASONE IMPURITY I (EP IMPURITY);BETAMETHASONE IMPURITY I [EP IMPURITY];8-FLUORO-11.BETA.,17,21-TRIHYDROXY-16.BETA.-METHYL-8.ALPHA.,9.BETA.-PREGNA-1,4-DIENE-3,20-DIONE;PREGNA-1,4-DIENE-3,20-DIONE, 8-FLUORO-11,17,21-TRIHYDROXY-16-METHYL-, (8ALPHA,9BETA,11BETA,16BETA)-;UNII-71SLU9RKCB;Q27265980;DTXSID10171795;8-Fluoro-11beta,17,21-trihydroxy-16beta-methyl-8alpha,9beta-pregna-1,4-diene-3,20-dione;

标识符

InChIKey:
CIWBQSYVNNPZIQ-JCOVECCMSA-N
Inchi:
1S/C28H37FO7/c1-6-23(33)35-15-22(32)28(36-24(34)7-2)16(3)12-20-19-9-8-17-13-18(30)10-11-25(17,4)27(19,29)21(31)14-26(20,28)5/h10-11,13,16,19-21,31H,6-9,12,14-15H2,1-5H3/t16-,19-,20-,21-,25-,26-,27?,28-/m0/s1
SMILES:
C[C@]12C[C@H](O)C3([C@](CCC4[C@]3(C)C=CC(=O)C=4)([H])[C@]1([H])C[C@H](C)[C@]2(OC(=O)CC)C(=O)COC(=O)CC)F

(8S,9R,10R,11S,13S,14R,16S,17R)-8-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one(185613-69-8)物化性质

计算特性

  • 精确分子量 : 392.19990218Da
  • 氢键供体数量 : 3
  • 氢键受体数量 : 6
  • 可旋转化学键数量 : 2
  • 同位素质量 : 392.19990218Da
  • 重原子数量 : 28
  • 复杂度 : 805
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 8
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 2
  • 拓扑分子极性表面积 : 94.8Ų

(8S,9R,10R,11S,13S,14R,16S,17R)-8-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one(185613-69-8)推荐厂家 更多厂家(6)

公司名称手机号/电话联系人QQ微信询单
深圳菲斯生物科技有限公司 18925202235周美娇 2850179284
询单
湖北扬信医药科技有限公司 18071854684
0714-3999001
程舒畅 2885409691
询单
湖北瑞诺医药科技有限公司 13165688766汪经理 3008058303
询单
深圳振强生物技术有限公司 13670046396
86-755-66853366
颜经理 2851296953
询单
南兴化工(江苏)有限公司 18651116180
0512-66387035
闵慧萍 3771156959 询单
上海柯维化学技术有限公司 18901607656
021-64609169
白荷 3428632096 询单